Environmental Epigenomics, Imprinting and Disease Susceptibility

National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Epigenetics: official journal of the DNA Methylation Society (Impact Factor: 4.78). 01/2006; 1(1):1-6. DOI: 10.4161/epi.1.1.2642
Source: PubMed


On Tuesday, November 2, 2005 over 450 scientists representing 14 nations converged on the Washington Duke Inn, Durham, NC, USA to discuss, learn and exchange information on how environmental influences can exert impacts on health not only on the individual that has been exposed but also for up to four subsequent generations in some human and animal models tested. The meeting entitled “Environmental Epigenomics, Imprinting and Disease Susceptibility” was sponsored by the National Institute of Environmental Health Sciences (NIEHS) and the Duke Comprehensive Cancer Center. The meeting featured presentations from many of the leading authorities/experts in epigenomics in the world and approximately 70 poster presentations, of which twelve were selected for oral presentation. The meeting was organized into nine scientific sessions spread over two and a half days that addressed the fetal basis of disease, epigenetics and gene regulation, epigenetics and cancer, therapeutic and reproductive cloning, stem cell differentiation, epigenetics and chronic diseases and epigenetics and neurodevelopment. The opening session introduced the meeting co-organizers, Randy Jirtle of Duke University Medical Center and Frederick Tyson of NIEHS, to conference participants and included greetings from. Christopher Willett, Chair of Duke Radiation Oncology Department, and William Schlessinger, Dean of the Nicolas School of the Environment and Earth Sciences. David Schwartz, Director of the NIEHS, set the tone for the conference with an overview lecture that identified research priorities of the NIEHS and pointed out the intersections between the environmental genomics component of NIEHS priorities and the environmental epigenomics. He noted that NIEHS research priorities will emphasize and coordinate efforts aimed at the study of complex human diseases. The environmental genomics infrastructural resources developed by NIEHS including over 500 re-sequenced environmentally responsive genes, over 50 humanized mouse strains, and progress towards establishing gene expression standards are available for utilization in the integration of epigenomic studies and the analysis of complex human diseases. Just as epigenomics is becoming increasingly more important in Schwartz’s own asthma research, this conference identified additional opportunities for the integration of environmental epigenomics and complex human disease.

Download full-text


Available from: Frederick Tyson, Dec 30, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Endometriosis is a complex gynecologic disorder in which alterations of specific biological processes involving both the endocrine and the immune systems have been identified. Recently, a reduced endometrial responsiveness to progesterone has been suggested as a crucial element in the pathophysiology of the disease but it is unclear whether this reduced sensitivity to the steroid is involved in the disease induction or is simply a consequence of the disease condition. Indeed, endometriosis is associated with a local and systemic inflammatory process that is strongly inter-related to the steroid activity, and both the systems mutually interact in a complex loop that strongly influences the disease development and maintenance. The link between prostaglandin E2 (PGE2), aromatase activity, and local estrogen synthesis represents a paradigm of this loop. A better understanding of the pathophysiology of this interaction should enable researchers to develop targeted therapeutics that may limit this self-supporting pathologic loop.
    Full-text · Article · Sep 2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ability of an environmental exposure to induce an epigenetic transgenerational adult onset disease phenotype is discussed in the current mini-review in the context of defining this phenomenon and the associated reproductive toxicology. A gestating female (F0 generation) exposure to an environmental compound results in the F1 generation embryo and F2 generation germ-line being directly exposed, such that the F3 generation is the first not directly exposed to the environmental compound. In contrast, postnatal or adult exposure (F0 generation) results in the F1 generation germ-line being exposed, such that F2 generation is the first to not be directly exposed to the environmental compound. The unequivocal transgenerational transmission of an adult onset disease phenotype through the germ-line requires assessment of the F3 generation for embryonic exposure, and F2 generation for postnatal exposure. This is in contrast to a number of F1 and F2 generation studies referred to as transgenerational. The reproductive toxicology associated with this transgenerational phenotype generally involves the reprogramming of the germ-line epigenome. The biological phenomenon involved in this reproductive toxicology deals with embryonic gonadal development and germ-line differentiation, or postnatally the gametogenesis process and germ cell development. The ability of an environmental compound (e.g. endocrine disruptor) to promote this reprogramming of the germ-line appears to be the causal factor in the epigenetic transgenerational phenotype.
    Preview · Article · Feb 2008 · Reproductive Toxicology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Laboratory and population-based studies suggest that exposure to environmental toxicants may be one of several triggers for the development of endometriosis. We discuss evidence that modulation of the endometrial endocrine-immune interface could mechanistically link toxicant exposure to the development of this disease.
    No preview · Article · Jun 2008 · Fertility and sterility
Show more